Advertisement
Advertisement
U.S. markets open in 7 hours 48 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Isracann Biosciences Inc. (ISCNF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0123+0.0006 (+4.77%)
At close: 03:36PM EST
Advertisement

Isracann Biosciences Inc.

595 Burrard Street
Suite 1600
Vancouver, BC V7X 1L3
Canada
604-394-2551
https://www.isracann.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Ms. Yana Popova CPACFO, Corp. Sec. & Director112.43kN/A1982
Mr. Matthew ChattertonChief Science Officer149.9kN/A1980
Ajay Singh KailaInterim Chief Exec. OfficerN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.

Corporate Governance

Isracann Biosciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement